Literature DB >> 28377112

The assessment of electrophysiological activity in human-induced pluripotent stem cell-derived cardiomyocytes exposed to dimethyl sulfoxide and ethanol by manual patch clamp and multi-electrode array system.

Soo-Wang Hyun1, Bo-Ram Kim2, Sung-Ae Hyun3, Joung-Wook Seo4.   

Abstract

INTRODUCTION: Recently, electrophysiological activity has been effectively measured in human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to predict drug-induced arrhythmia. Dimethyl sulfoxide (DMSO) and ethanol have been used as diluting agents in many experiments. However, the maximum DMSO and ethanol concentrations that can be effectively used in the measurement of electrophysiological parameters in hiPSC-CMs-based patch clamp and multi-electrode array (MEA) have not been fully elucidated.
METHODS: We investigated the effects of varying concentrations of DMSO and ethanol used as diluting agents on several electrophysiological parameters in hiPSC-CMs using patch clamp and MEA.
RESULTS: Both DMSO and ethanol at concentrations>1% in external solution resulted in osmolality >400mOsmol/kg, but pH was not affected by either agent. Neither DMSO nor ethanol led to cell death at the concentrations examined. However, resting membrane potential, action potential amplitude, action potential duration at 90% and 40%, and corrected field potential duration were decreased significantly at 1% ethanol concentration. DMSO at 1% also significantly decreased the sodium spike amplitude. In addition, the waveform of action potential and field potential was recorded as irregular at 3% concentrations of both DMSO and ethanol. Concentrations of up to 0.3% of either agent did not affect osmolality, pH, cell death, or electrophysiological parameters in hiPSC-CMs. DISCUSSION: Our findings suggest that 0.3% is the maximum concentration at which DMSO or ethanol should be used for dilution purposes in hiPSC-CMs-based patch clamp and MEA.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dimethyl sulfoxide (DMSO); Ethanol; Human-induced pluripotent stem cells-derived cardiomyocytes (hiPSC-CMs); Multi-electrode array (MEA); Patch clamp technique

Mesh:

Substances:

Year:  2017        PMID: 28377112     DOI: 10.1016/j.vascn.2017.03.003

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  5 in total

1.  NanoMEA: A Tool for High-Throughput, Electrophysiological Phenotyping of Patterned Excitable Cells.

Authors:  Alec S T Smith; Eunpyo Choi; Kevin Gray; Jesse Macadangdang; Eun Hyun Ahn; Elisa C Clark; Michael A Laflamme; Joseph C Wu; Charles E Murry; Leslie Tung; Deok-Ho Kim
Journal:  Nano Lett       Date:  2019-12-23       Impact factor: 11.189

2.  Nanocrown electrodes for parallel and robust intracellular recording of cardiomyocytes.

Authors:  Zeinab Jahed; Yang Yang; Ching-Ting Tsai; Ethan P Foster; Allister F McGuire; Huaxiao Yang; Aofei Liu; Csaba Forro; Zen Yan; Xin Jiang; Ming-Tao Zhao; Wei Zhang; Xiao Li; Thomas Li; Annalisa Pawlosky; Joseph C Wu; Bianxiao Cui
Journal:  Nat Commun       Date:  2022-04-26       Impact factor: 17.694

3.  Pharmacological Profile of the Sodium Current in Human Stem Cell-Derived Cardiomyocytes Compares to Heterologous Nav1.5+β1 Model.

Authors:  Dieter V Van de Sande; Ivan Kopljar; Ard Teisman; David J Gallacher; Dirk J Snyders; Hua Rong Lu; Alain J Labro
Journal:  Front Pharmacol       Date:  2019-12-11       Impact factor: 5.810

4.  Adipose stem cell-derived extracellular vesicles ameliorates corticosterone-induced apoptosis in the cortical neurons via inhibition of ER stress.

Authors:  Sung-Ae Hyun; Young Ju Lee; Sumi Jang; Moon Yi Ko; Chang Youn Lee; Yong Woo Cho; Ye Eun Yun; Byoung-Seok Lee; Joung-Wook Seo; Kyoung-Sik Moon; Minhan Ka
Journal:  Stem Cell Res Ther       Date:  2022-03-21       Impact factor: 6.832

5.  Interrelated In Vitro Mechanisms of Sibutramine-Induced Cardiotoxicity.

Authors:  Feyza Alyu; Yusuf Olgar; Sinan Degirmenci; Belma Turan; Yusuf Ozturk
Journal:  Cardiovasc Toxicol       Date:  2021-01-03       Impact factor: 3.231

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.